ImmuCell Corp banner

ImmuCell Corp
NASDAQ:ICCC

Watchlist Manager
ImmuCell Corp Logo
ImmuCell Corp
NASDAQ:ICCC
Watchlist
Price: 6.44 USD 0.78% Market Closed
Market Cap: $58.3m

ImmuCell Corp
Goodwill

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

ImmuCell Corp
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Goodwill CAGR 3Y CAGR 5Y CAGR 10Y
ImmuCell Corp
NASDAQ:ICCC
Goodwill
$95.6k
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Goodwill
$35.6B
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
10%
Gilead Sciences Inc
NASDAQ:GILD
Goodwill
$8.3B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
22%
Amgen Inc
NASDAQ:AMGN
Goodwill
$18.7B
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
2%
Exact Sciences Corp
NASDAQ:EXAS
Goodwill
$2.4B
CAGR 3-Years
0%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Goodwill
$1.1B
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
36%
No Stocks Found

ImmuCell Corp
Glance View

Market Cap
58.3m USD
Industry
Biotechnology

ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company is headquartered in Portland, Maine and currently employs 60 full-time employees. The firm is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. The company manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. The company expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens, as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The firm is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.

ICCC Intrinsic Value
4.78 USD
Overvaluation 26%
Intrinsic Value
Price

See Also

What is ImmuCell Corp's Goodwill?
Goodwill
95.6k USD

Based on the financial report for Dec 31, 2025, ImmuCell Corp's Goodwill amounts to 95.6k USD.

What is ImmuCell Corp's Goodwill growth rate?
Goodwill CAGR 5Y
-1%

Over the last year, the Goodwill growth was 0%. The average annual Goodwill growth rates for ImmuCell Corp have been -1% over the past three years , -1% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett